Global Anti-Inflammatory Therapeutics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Anti-Inflammatory Therapeutics Market was valued at $118 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $164 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global anti-inflammatory therapeutics market comprises pharmaceutical agents including biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and targeted small-molecule inhibitors. These therapies are utilized to manage acute and chronic inflammation associated with autoimmune disorders, respiratory diseases, and musculoskeletal conditions such as rheumatoid arthritis, psoriasis, and asthma.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Anti-Inflammatory Therapeutics Market in the period 2025-30:
- The rising prevalence of chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease is the primary driver for market expansion.
- A significant shift toward precision medicine is occurring as clinicians move from broad-spectrum NSAIDs to highly targeted biologics and monoclonal antibodies.
- The global aging population is increasing the demand for long-term management of age-related inflammatory and musculoskeletal conditions.
- The entry of biosimilars for blockbuster drugs like Humira is increasing market competition and expanding patient access through lower costs.
- Integration of Artificial Intelligence in drug discovery is accelerating the identification of novel biomarkers and optimizing clinical trial designs.
- Regulatory support through fast-track designations is expediting the approval of next-generation therapies for unmet medical needs.
- There is an increasing focus on safety profiles to reduce the systemic side effects associated with long-term corticosteroid and traditional drug use.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Anti-inflammatory Biologics
- NSAIDs
- Corticosteroids
- Other Targeted Molecules